A Clinical Study to Evaluate the Pharmacokinetic Profile of SB-649868 in Elderly and Female Population

Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia

NCT00608985 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

NCT03679884 ·Status: COMPLETED ·Phase: PHASE3

Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep Loss

NCT01096680 ·Status: COMPLETED ·Phase: PHASE2

Insomnia and Daytime Function in Osteoarthritis

NCT00530556 ·Status: COMPLETED ·Phase: PHASE4

A Study to Assess the Pharmacodynamic Effects of SAGE-217 in Healthy Adults Using an Insomnia Model

NCT03284931 ·Status: COMPLETED ·Phase: PHASE1

A Study of Daridorexant in Chinese Patients With Insomnia Disorder

NCT06010693 ·Status: COMPLETED ·Phase: PHASE3

A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With Esmirtazapine (Org 50081) (P05707)

NCT00506389 ·Status: COMPLETED ·Phase: PHASE3

Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia

NCT00606593 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder

NCT07028697 ·Status: COMPLETED ·Phase: PHASE3

Stilnox Treatment in Elderly Patients With Insomnia

NCT00359229 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274

NCT02852395 ·Status: COMPLETED ·Phase: PHASE1

Sleep Satisfaction and Psychomotor Performance of Adults

NCT01097382 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

NCT03575104 ·Status: COMPLETED ·Phase: PHASE3

Lemborexant vs Zopiclone vs Clonidine for Insomnia Treatment in Chronic Pain Patients

NCT05618002 ·Status: RECRUITING

Long-Term Study of TS-142 in Patients with Insomnia

NCT05461352 ·Status: COMPLETED ·Phase: PHASE3

Phase III Study of TS-142 in Patients with Insomnia

NCT05453136 ·Status: COMPLETED ·Phase: PHASE3

Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2)

NCT02952820 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary Insomnia

NCT00630175 ·Status: COMPLETED ·Phase: PHASE3

A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia

NCT00386334 ·Status: COMPLETED ·Phase: PHASE4

Treating Insomnia and Improving Metabolic Health in Midlife Women With Insomnia

NCT05593653 ·Status: COMPLETED ·Phase: PHASE4

An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)

NCT00103818 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder

NCT03545191 ·Status: COMPLETED ·Phase: PHASE3

Disturbed Sleep Model Study.

NCT00440323 ·Status: COMPLETED ·Phase: PHASE1

Driving Performance After Middle of the Night Administration of 3.5 mg Zolpidem Tartrate Sublingual Tablet

NCT01106859 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness

NCT01124851 ·Status: COMPLETED ·Phase: PHASE1